SCLX Scilex Holding Total Business Assets

SCLX (Scilex Holding Co.) - company brandmark

Stability is a biopharmaceutical business developing non-opioid patches for pain management, which ensures a steady cash flow and high margins. This chart of Scilex Holding Company (SCLX) aggregate assets currently reflects a level of 168.66. Scilex Holding Company (SCLX) has established a comprehensive distribution and production network, becoming a key supplier of safe medications. Pipeline development is focused on implementing new injectable forms and expanding therapeutic areas.

Cumulative Company Assets: Scilex Holding Company (SCLX) for 04/28/2023 - 11/01/2026

Analytical breakdowns and data insights for company Scilex Holding Co. (SCLX)

- stock quotes and analyst forecast:
Share Price scilexholding.com|SCLX - Price Target Chart
- market capitalization data:
Market Capitalization Scilex Holding Company, Inc.|SCLX - Enterprise Value
- book capitalization information:
Net Asset Value per Share Scilex Holding Company|SCLX - Company Net Assets|Market Capitalization to Book Value Ratio scilexholding.com|SCLX - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Scilex Holding Company|SCLX - Long-Term Debt to Equity|Current Liabilities to Capital Scilex Holding Company, Inc.|SCLX - Company Debts|Debts to Net Assets Scilex Holding Company, Inc.|SCLX - Company Long-Term Debts|Company Current Liabilities Scilex Holding Company|Interim Coverage Ratio scilexholding.com
- company profitability and valuation multiples indicators:
SCLX - Company Net Income
Basic company analysis:SCLX - scilexholding.com
Manufactured products of Scilex

Investors are assessing the resilience of Scilex Holding Company (SCLX) through the balance of resources and debt load. Patent protection for non-opioid drugs ensures a stable cash flow, which should effectively convert into growth of the asset base. By analyzing fluctuations in total assets calculated inversely via ROA, one can track operational capital dynamics without waiting for reports. This indicator determines the real scale of the business, allowing investors to avoid overpaying for an inflated asset complex.

Direct competitors

Total Business Assets BIIB|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|Aggregate Company Assets Biohaven Ltd.|amylyx.com (AMLX) - Company Total Asset Base|Company Total Assets TRVI|Cumulative Company Assets Praxis Precision Medicines Inc PRAX|Company Total Assets AVXL (Anavex Corp)|Company Total Asset Base CeriBell EEG (CBLL)|PRTA - Aggregate Company Assets|ALEC: Aggregate Company Assets|ANNX: Company Total Assets|Company Assets Omeros (OMER)|Cumulative Company Assets NGNE|Total Business Assets ACIU (AC Immune Inc)|Cumulative Company Assets VYGR (Voyager Therapeutics)|NMRA (neumoratx.com) - Aggregate Asset Value|Company Total Assets TVGN (Tevogen Bio)|Aggregate Asset Value ACOG|CGTX - Aggregate Company Assets|Company Assets Inhibikase Pharma|Cassava Sciences, Inc. (SAVA) - Aggregate Company Assets|ASRT (Assertio) - Aggregate Company Assets|COYA (Coya Therapeutics Inc) - Company Total Assets|Total Business Assets VTGN (VistaGen Therapeutics Inc)|Company Total Assets OVID|Company Total Asset Base Acumen Pharmaceuticals, Inc|Aggregate Company Assets CervoMed Inc. CRVO|ATHE: Total Business Assets|Clene Nanomedicine - Company Total Assets|Company Balance Sheet Assets PepGen Inc. (PEPG)|JUNS (Jupiter Neurosciences) - Cumulative Company Assets|Relmada Corp - Aggregate Asset Value|ANVS (Annovis Bio, Inc.) - Company Total Assets|Cumulative Company Assets Grace Tx (GRCE)|Aggregate Company Assets Firefly Neuroscience (AIFF)|KLTO - Company Assets|Aggregate Company Assets NeuroSense Therapeutics Ltd. NRSN|RVPH - Cumulative Company Assets|MTVA - Aggregate Company Assets|Total Asset Value of Company NRXS|HSDT: Company Total Assets|Passage Bio (PASG) - Company Total Assets|Aggregate Company Assets Neuphoria Therapeutics, Inc.|Total Business Assets NERV (Minerva)|Cumulative Company Assets ATHA (Athira Pharma, Inc.)|ADXN - Company Assets|Aggregate Company Assets Alzamend Neuro ALZN|Company Total Asset Base Cyclerion Therapeutics Inc. (CYCN)|Protagenic - Company Total Assets|Pasithea Therapeutics (KTTA) - Cumulative Company Assets|cortigent.com (CRGT) - Aggregate Company Assets|ATXI (avenuetx.com) - Aggregate Company Assets|Cumulative Company Assets BCLI|Total Business Assets CARA (Cara Therapeutics Inc.)|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|eliemtx.com - Total Business Assets|Company Total Assets ITCI (Intra-Cellular Therapies, Inc.)|longboardpharma.com (LBPH) - Company Assets|MRNS: Cumulative Company Assets|NKGN - Company Total Assets|NeuroBo (NRBO) - Aggregate Company Assets|Sage Therapeutics Inc - Aggregate Asset Value|Aggregate Company Assets Synaptogenix, Inc.|Company Assets trevena.com TRVN|Aggregate Company Assets Vigil Neuroscience (VIGL)|Company Total Asset Base anewmeds.com|Company Total Assets CERE (Cerevel)